Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines, today announced interim data from a phase 1b study of ABX1100 ...
Having different chronotypes, or being more active in the morning vs. afternoon, may play an important role in preserving muscle mass and strength, and metabolic health, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results